Finerenone for CKD in type 2 diabetes (Nice, March 2023)

6th April 2023 by Dr Louise Hudman

Finerenone for CKD in type 2 diabetes (Nice, March 2023)

This is a new guideline from Nice advising that we can use finerenone for selected patients with CKD and type 2 diabetes.

What is finerenone?

It is a non-steroidal mineralocorticoid receptor antagonist. According to the BNF it “inhibits receptor-mediated sodium reabsorption and decreases receptor overactivation, thereby reducing the inflammation and fibrosis that lead to kidney damage”.

Why is CKD such an issue for people with T2DM?

This is summarised from what Nice has put in their guideline.

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

Related content

"LocumDeck does everything you want it to do in an instant.

I absolutely love the facility for receiving locums' invoices and the facility for signing pension forms electronically. They are then instantly sent with an audit trail. It is fabulous!

You are notified the moment a GP locum adds availability, which is just fantastic. I spend a lot of time just chasing agencies to see if they have availability, so to be notified the moment availability is advertised is a new concept, and very welcome.

I have no hesitation in recommending LocumDeck – it has already eased my workload."

Sue, practice manager, Portsmouth

See the full list of features within our NASGP membership plans

Membership